Delivery Order SPE2DB22D3016-SPE2DB25FAYP2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,117.25 on July 22, 2025, for the supply of Quillichew ER 20 MG chew tablets (100-count units). This firm fixed-price, competitively awarded contract represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,676.97 to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100 count) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Quillichew ER 20 mg chew tablets (100 count) with a ceiling value of $1,566.46. This firm fixed-price delivery order is set to be completed by August 27, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a non-set-aside, competitively awarded procurement executed under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Quillichew ER 40 mg chew tablets (100-count units) with a ceiling value of $1,341.21. This is a firm fixed price delivery order executed under a non-competitive set-aside structure, with performance to be completed by August 8, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,879.40 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.06 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract employs firm fixed price terms and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,781.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100-count units). The contract was competitively awarded without set-aside provisions and was completed on August 26, 2025, one day after the award date of August 25, 2025. Performance of this delivery order was conducted at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Quillichew ER 40 mg chewable tablets (100-count units) with a ceiling value of $1,554.57. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 9, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100-count units) valued at $3,095.96. This competitively awarded, firm fixed-price contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAYP2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,047.54 to AmerisourceBergen Drug Corp for Quillichew ER 40 mg chewable tablets (100-count units) on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be sourced from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate office operations. This delivery order is a child contract under AmerisourceBergen's $999.999 billion DLA Troop Support Medical IDC, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial portfolio of federal contracts delivering medications across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Quillichew (chewable methylphenidate) is a prescription medication used to treat attention deficit hyperactivity disorder, reflecting the company's role in supplying specialized pharmaceutical commodities to military medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/6/25 |